News FDA approves UCB’s Cimzia in plaque psoriasis The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
News Escalier raises $19m to fund novel psoriasis pill Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.
News Novartis trumpets long-term data for Cosentyx in psoriasis Novartis is hoping that new real world data will help its psoriasis drug Cosentyx stay ahead of rivals.
News AbbVie to file long-acting psoriasis contender AbbVie hopes risankizumab will rebuild sales after Humira patent expires
News Bioelectronic wearable shows promise in psoriasis Thync's bioelectronic wearable significantly reduced symptoms in psoriasis patients within four weeks of use.
News J&J's psoriasis drug faces crowded market after US approval J&J taking on next gen drugs from Novartis, Eli Lilly, and Valeant.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
